Constellium (CSTM) Financials

$11.18 +0.40 (+3.71%)

Closing price 05/2/2025 03:59 PM Eastern

Extended Trading

$11.17 -0.01 (-0.10%)

As of 08:58 AM Eastern

Annual Income Statements for Constellium

This table shows Constellium's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-600	-4.21	-37	220	77	-26	291	308	152	56
Consolidated Net Income / (Loss)	-600	-4.21	-37	217	72	-21	297	315	157	60
Net Income / (Loss) Continuing Operations	-600	-4.21	-37	217	72	-21	297	315	157	60
Total Pre-Tax Income	-635	68	59	254	92	-42	359	150	232	135
Total Operating Income	-463	259	322	287	312	153	548	343	386	272
Total Gross Profit	489	563	667	616	676	599	752	963	1,055	938
Total Revenue	5,431	4,990	6,291	6,508	6,629	5,965	6,963	8,532	7,826	7,335
Operating Revenue	5,431	4,990	6,291	6,508	6,629	5,965	6,963	8,532	7,826	7,335
Total Cost of Revenue	5,110	4,427	5,624	5,892	5,954	5,367	6,211	7,569	6,771	6,397
Operating Cost of Revenue	5,110	4,427	5,624	5,892	5,954	5,367	6,211	7,569	6,771	6,397
Total Operating Expenses	809	304	345	328	364	446	204	620	669	666
Selling, General & Admin Expense	266	266	297	283	310	290	292	284	317	313
Research & Development Expense	38	33	43	46	54	48	44	46	52	49
Depreciation Expense	-	-	-	-	-	-	-	290	300	304
Total Other Income / (Expense), net	-142	-190	-263	-33	-220	-194	-189	-193	-154	-137
Interest Expense	-	198	312	208	194	-	-	103	111	111
Other Income / (Expense), net	-142	22	84	175	-26	-	-	-90	-43	-26
Income Tax Expense	-35	73	96	37	20	-21	62	-165	75	75
Net Income / (Loss) Attributable to Noncontrolling Interest	-	0.00	0.00	-2.29	-5.61	-4.89	-5.66	7.00	5.00	4.00
Basic Earnings per Share	-	($0.04)	($0.28)	$1.40	$0.43	($0.15)	$1.82	$2.14	$1.04	$0.38
Weighted Average Basic Shares Outstanding	-	-	134.51M	134.76M	136.86M	138.74M	141.00M	144.30M	146.82M	143.52M
Diluted Earnings per Share	-	($0.04)	($0.28)	$1.37	$0.41	($0.15)	$1.75	$2.10	$1.03	$0.38
Weighted Average Diluted Shares Outstanding	-	-	134.51M	138.15M	142.65M	138.74M	147.17M	144.30M	146.82M	143.52M
Weighted Average Basic & Diluted Shares Outstanding	-	-	134.51M	136.00M	137.87M	139.96M	141.68M	144.30M	146.82M	143.52M

This table shows Constellium's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025
Period end date	3/31/2025
Net Income / (Loss) Attributable to Common Shareholders	37
Consolidated Net Income / (Loss)	38
Net Income / (Loss) Continuing Operations	38
Total Pre-Tax Income	62
Total Operating Income	94
Total Gross Profit	263
Total Revenue	1,979
Operating Revenue	1,979
Total Cost of Revenue	1,716
Operating Cost of Revenue	1,716
Total Operating Expenses	169
Selling, General & Admin Expense	78
Research & Development Expense	13
Depreciation Expense	78
Total Other Income / (Expense), net	-32
Interest Expense	27
Other Income / (Expense), net	-5.00
Income Tax Expense	24
Net Income / (Loss) Attributable to Noncontrolling Interest	1.00
Basic Earnings per Share	$0.26
Weighted Average Basic Shares Outstanding	142.92M
Diluted Earnings per Share	$0.26
Weighted Average Diluted Shares Outstanding	142.92M
Weighted Average Basic & Diluted Shares Outstanding	142.92M

This table details how cash moves in and out of Constellium's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-827	-139	-85	-122	20	316	-338	19	39	-73
Net Cash From Operating Activities	-600	93	192	76	502	408	404	365	432	301
Net Cash From Continuing Operating Activities	-600	93	192	76	502	408	404	365	432	301
Net Income / (Loss) Continuing Operations	-600	-4.21	-37	217	72	-21	297	315	157	60
Consolidated Net Income / (Loss)	-600	-4.21	-37	217	72	-21	297	315	157	60
Depreciation Expense	-	163	205	225	287	316	302	290	300	304
Non-Cash Adjustments To Reconcile Net Income	-	203	360	66	155	186	238	-82	53	73
Changes in Operating Assets and Liabilities, net	-	-269	-336	-434	-12	-73	-432	-158	-78	-136
Net Cash From Investing Activities	4.35	-384	-351	-104	-396	-215	-250	-196	-216	-313
Net Cash From Continuing Investing Activities	4.35	-384	-351	-104	-396	-215	-250	-196	-216	-313
Purchase of Property, Plant & Equipment	-	-	-	-	-	-	-	-289	-366	-413
Acquisitions	-	22	0.00	0.00	-93	-	-	0.00	0.00	3.00
Divestitures	4.35	-	-	-	-	-	-	0.00	51	0.00
Other Investing Activities, net	-	-27	-22	-16	-1.12	0.00	0.00	93	99	97
Net Cash From Financing Activities	-231	153	73	-94	-85	123	-492	-150	-177	-61
Net Cash From Continuing Financing Activities	-231	153	73	-94	-85	123	-492	-150	-177	-61
Repayment of Debt	-229	-156	-1,873	-1.14	-117	-255	-1,191	-130	-155	-640
Repurchase of Common Equity	-	-	-	-	-	-	-	0.00	0.00	-79
Payment of Dividends	-	-2.10	0.00	0.00	-4.49	0.00	-2.26	-2.00	-3.00	-5.00
Issuance of Debt	-	322	1,765	-77	127	442	800	0.00	0.00	671
Other Financing Activities, net	-2.17	-12	-130	-16	-91	-64	-100	-18	-19	-8.00

This table details how cash moves in and out of Constellium's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025
Period end date	3/31/2025
Net Change in Cash & Equivalents	-27
Net Cash From Operating Activities	58
Net Cash From Continuing Operating Activities	58
Net Income / (Loss) Continuing Operations	38
Consolidated Net Income / (Loss)	38
Depreciation Expense	78
Non-Cash Adjustments To Reconcile Net Income	24
Changes in Operating Assets and Liabilities, net	-82
Net Cash From Investing Activities	-59
Net Cash From Continuing Investing Activities	-59
Purchase of Property, Plant & Equipment	-69
Other Investing Activities, net	10
Net Cash From Financing Activities	-26
Net Cash From Continuing Financing Activities	-26
Repayment of Debt	-7.00
Repurchase of Common Equity	-15
Payment of Dividends	-2.00
Other Financing Activities, net	-2.00

This table presents Constellium's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	3,984	4,458	4,465	4,696	5,044	5,233	5,286	4,933	4,734
Total Current Assets	1,483	1,682	1,649	1,515	1,791	3,198	787	1,992	1,834
Cash & Equivalents	365	323	188	206	536	166	178	223	141
Accounts Receivable	373	503	672	532	496	773	577	531	486
Inventories, net	622	772	755	752	711	2,193	-	1,197	1,181
Other Current Assets	-	-	-	-	-	-	-	41	26
Plant, Property, & Equipment, net	1,554	1,822	1,907	2,307	2,328	2,205	0.00	2,422	2,408
Total Noncurrent Assets	947	954	909	873	925	835	929	519	492
Noncurrent Note & Lease Receivables	-	-	-	-	-	-	-	34	36
Goodwill	481	484	483	511	509	510	511	41	46
Intangible Assets	83	82	80	79	75	66	58	104	97
Noncurrent Deferred & Refundable Income Taxes	265	197	260	275	236	183	290	337	311
Other Noncurrent Operating Assets	101	190	85	7.86	105	76	55	3.00	2.00
Total Liabilities & Shareholders' Equity	3,984	4,458	4,465	4,696	5,044	5,233	5,286	4,933	4,734
Total Liabilities	4,584	4,841	4,595	4,791	5,167	4,904	4,481	4,191	4,007
Total Current Liabilities	1,075	1,333	1,201	1,428	1,327	1,940	1,822	1,556	1,446
Short-Term Debt	113	127	-	226	112	292	202	41	39
Accounts Payable	883	1,117	1,139	1,121	1,106	1,558	1,592	1,411	1,309
Current Deferred & Payable Income Tax Liabilities	-	13	9.16	16	24	38	-	22	18
Current Employee Benefit Liabilities	-	-	-	-	-	-	-	24	22
Other Current Liabilities	80	76	53	65	84	51	-	58	58
Total Noncurrent Liabilities	3,495	3,508	3,395	3,363	3,841	2,964	2,660	2,635	2,561
Long-Term Debt	2,484	2,428	2,462	2,424	2,808	2,118	2,056	1,888	1,879
Noncurrent Deferred & Payable Income Tax Liabilities	32	30	25	27	12	16	30	35	39
Noncurrent Employee Benefit Liabilities	773	798	698	752	811	678	431	431	375
Other Noncurrent Operating Liabilities	206	252	209	160	209	153	142	281	268
Commitments & Contingencies	-	-	-	-	-	-	-	0.00	0.00
Total Equity & Noncontrolling Interests	-600	-383	-130	-95	-123	329	804	742	727
Total Preferred & Common Equity	-609	-393	-140	-95	-264	310	782	718	706
Total Common Equity	-609	-393	-140	-579	-654	-165	333	718	706
Common Stock	2.10	3.60	3.43	3.37	3.66	3.40	3.21	517	517
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-	-	-	0.00	-14
Other Equity Adjustments	170	505	-143	-	-657	-169	329	201	203
Noncontrolling Interest	9.47	9.61	9.16	12	17	19	22	24	21

This table presents Constellium's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025
Period end date	3/31/2025
Total Assets	5,168
Total Current Assets	2,236
Cash & Equivalents	118
Accounts Receivable	818
Inventories, net	1,278
Other Current Assets	22
Plant, Property, & Equipment, net	2,456
Total Noncurrent Assets	476
Noncurrent Note & Lease Receivables	38
Goodwill	46
Intangible Assets	94
Noncurrent Deferred & Refundable Income Taxes	294
Other Noncurrent Operating Assets	4.00
Total Liabilities & Shareholders' Equity	5,168
Total Liabilities	4,403
Total Current Liabilities	1,808
Short-Term Debt	35
Accounts Payable	1,665
Current Deferred & Payable Income Tax Liabilities	17
Current Employee Benefit Liabilities	23
Other Current Liabilities	68
Total Noncurrent Liabilities	2,595
Long-Term Debt	1,908
Noncurrent Deferred & Payable Income Tax Liabilities	48
Noncurrent Employee Benefit Liabilities	377
Other Noncurrent Operating Liabilities	262
Commitments & Contingencies	0.00
Total Equity & Noncontrolling Interests	765
Total Preferred & Common Equity	745
Total Common Equity	745
Common Stock	517
Accumulated Other Comprehensive Income / (Loss)	-1.00
Other Equity Adjustments	229
Noncontrolling Interest	20

This table displays calculated financial ratios and metrics derived from Constellium's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-8.12%	26.08%	3.45%	1.87%	-10.02%	16.73%	22.54%	-8.27%	-6.27%
EBITDA Growth	0.00%	173.35%	37.73%	12.50%	-16.63%	-18.20%	81.20%	-36.12%	18.42%	-14.46%
EBIT Growth	0.00%	146.41%	44.55%	13.88%	-38.11%	-46.64%	258.74%	-53.81%	35.57%	-28.28%
NOPAT Growth	0.00%	95.08%	-1,178.89%	220.72%	-0.96%	-56.10%	323.56%	59.09%	-63.74%	-53.72%
Net Income Growth	0.00%	99.30%	-784.95%	683.96%	-66.97%	-128.91%	1,527.88%	6.23%	-50.16%	-61.78%
EPS Growth	0.00%	0.00%	-600.00%	589.29%	-70.07%	-136.59%	1,266.67%	20.00%	-50.95%	-63.11%
Operating Cash Flow Growth	0.00%	115.44%	107.61%	-60.70%	564.11%	-18.67%	-0.97%	-9.67%	18.36%	-30.32%
Free Cash Flow Firm Growth	0.00%	0.00%	69.57%	78.89%	130.44%	624.07%	-492.79%	685.85%	-158.71%	102.23%
Invested Capital Growth	0.00%	0.00%	17.22%	19.47%	10.14%	-4.67%	58.66%	-120.56%	439.00%	2.29%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	9.00%	11.28%	10.60%	9.46%	10.19%	10.03%	10.79%	11.29%	13.48%	12.79%
EBITDA Margin	-11.14%	8.90%	9.72%	10.57%	8.65%	7.86%	12.21%	6.36%	8.22%	7.50%
Operating Margin	-8.52%	5.19%	5.12%	4.41%	4.71%	2.56%	7.87%	4.02%	4.93%	3.71%
EBIT Margin	-11.14%	5.63%	6.45%	7.11%	4.32%	2.56%	7.87%	2.97%	4.38%	3.35%
Profit (Net Income) Margin	-11.04%	-0.08%	-0.59%	3.34%	1.08%	-0.35%	4.26%	3.69%	2.01%	0.82%
Tax Burden Percent	94.52%	-6.15%	-63.27%	85.59%	78.05%	50.00%	82.65%	210.00%	67.67%	44.44%
Interest Burden Percent	104.85%	24.34%	14.50%	54.95%	32.16%	-27.20%	65.50%	59.29%	67.64%	54.88%
Effective Tax Rate	0.00%	106.15%	163.27%	14.41%	21.95%	0.00%	17.35%	-110.00%	32.33%	55.56%
Return on Invested Capital (ROIC)	0.00%	-2.12%	-12.46%	12.70%	10.99%	4.71%	15.82%	51.64%	30.27%	4.88%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-1.00%	-4.63%	11.40%	3.62%	-0.66%	10.15%	2.69%	-85.91%	1.39%
Return on Net Nonoperating Assets (RNNOA)	0.00%	3.52%	20.03%	-97.36%	-74.59%	14.27%	272.12%	3.93%	-9.97%	3.29%
Return on Equity (ROE)	0.00%	1.40%	7.58%	-84.67%	-63.60%	18.99%	287.93%	55.56%	20.30%	8.17%
Cash Return on Invested Capital (CROIC)	0.00%	-202.12%	-28.31%	-5.05%	1.34%	9.49%	-29.54%	0.00%	-118.83%	2.62%
Operating Return on Assets (OROA)	0.00%	7.05%	9.62%	10.36%	6.25%	3.14%	10.66%	4.81%	6.71%	5.09%
Return on Assets (ROA)	0.00%	-0.11%	-0.88%	4.87%	1.57%	-0.43%	5.77%	5.99%	3.07%	1.24%
Return on Common Equity (ROCE)	0.00%	1.43%	7.72%	-87.76%	-202.38%	106.97%	-1,144.63%	8.21%	13.79%	7.92%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.69%	9.48%	-155.74%	-75.29%	7.87%	95.62%	40.28%	21.87%	8.50%
Net Operating Profit after Tax (NOPAT)	-324	-16	-204	246	244	107	453	720	261	121
NOPAT Margin	-5.97%	-0.32%	-3.24%	3.78%	3.67%	1.79%	6.50%	8.44%	3.34%	1.65%
Net Nonoperating Expense Percent (NNEP)	0.00%	-1.11%	-7.83%	1.30%	7.37%	5.37%	5.66%	48.95%	116.19%	3.50%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	23.52%	9.78%	4.57%
Cost of Revenue to Revenue	94.10%	88.72%	89.40%	90.54%	89.81%	89.97%	89.21%	88.71%	86.52%	87.21%
SG&A Expenses to Revenue	4.90%	5.33%	4.72%	4.34%	4.67%	4.85%	4.19%	3.33%	4.05%	4.27%
R&D to Revenue	0.70%	0.65%	0.69%	0.70%	0.81%	0.80%	0.63%	0.54%	0.66%	0.67%
Operating Expenses to Revenue	14.91%	6.09%	5.48%	5.05%	5.49%	7.47%	2.93%	7.27%	8.55%	9.08%
Earnings before Interest and Taxes (EBIT)	-605	281	406	462	286	153	548	253	343	246
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-605	444	611	688	573	469	850	543	643	550
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.04	4.01	2.14
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.03	2.68
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.14	0.27	0.32	0.36	0.20	0.37	0.21
Price to Earnings (P/E)	0.00	0.00	0.00	4.28	23.53	0.00	8.62	5.44	18.95	26.93
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	23.37%	4.25%	0.00%	11.60%	18.38%	5.28%	3.71%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	1.53	2.04	2.19	1.49	0.00	1.88	1.32
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.50	0.72	0.81	0.75	0.50	0.59	0.45
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	4.68	8.28	10.33	6.17	7.79	7.17	6.01
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	6.97	16.59	31.72	9.57	16.71	13.44	13.44
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	13.11	19.50	45.31	11.58	5.87	17.65	27.35
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	42.66	9.47	11.87	12.98	11.59	10.67	10.98
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	159.68	22.50	0.00	0.85	0.00	50.95
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	-4.33	-6.67	-18.87	-27.78	-23.67	7.32	2.81	2.60	2.64
Long-Term Debt to Equity	0.00	-4.14	-6.34	-18.87	-25.41	-22.76	6.43	2.56	2.54	2.58
Financial Leverage	0.00	-3.51	-4.33	-8.54	-20.61	-21.73	26.80	1.46	0.12	2.37
Leverage Ratio	0.00	-6.64	-8.59	-17.37	-40.56	-44.52	49.90	9.28	6.61	6.58
Compound Leverage Factor	0.00	-1.62	-1.25	-9.55	-13.04	12.11	32.68	5.50	4.47	3.61
Debt to Total Capital	0.00%	130.03%	117.64%	105.60%	103.73%	104.41%	87.98%	73.73%	72.22%	72.51%
Short-Term Debt to Total Capital	0.00%	5.64%	5.86%	0.00%	8.83%	4.02%	10.66%	6.60%	1.54%	1.47%
Long-Term Debt to Total Capital	0.00%	124.39%	111.78%	105.60%	94.90%	100.39%	77.31%	67.13%	70.69%	71.04%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	18.45%	18.34%	17.36%	14.67%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.47%	0.44%	0.39%	0.48%	0.61%	0.70%	0.73%	0.90%	0.79%
Common Equity to Total Capital	0.00%	-30.51%	-18.09%	-5.99%	-22.67%	-23.36%	-6.03%	10.86%	26.88%	26.69%
Debt to EBITDA	0.00	5.85	4.18	3.58	4.62	6.23	2.83	4.16	3.00	3.49
Net Debt to EBITDA	0.00	4.99	3.65	3.30	4.26	5.08	2.64	3.83	2.65	3.23
Long-Term Debt to EBITDA	0.00	5.59	3.97	3.58	4.23	5.99	2.49	3.79	2.94	3.42
Debt to NOPAT	0.00	-163.03	-12.54	10.01	10.88	27.33	5.32	3.14	7.38	15.87
Net Debt to NOPAT	0.00	-139.05	-10.95	9.25	10.03	22.31	4.95	2.89	6.53	14.70
Long-Term Debt to NOPAT	0.00	-155.96	-11.92	10.01	9.96	26.27	4.68	2.85	7.23	15.54
Altman Z-Score	0.00	0.00	0.00	2.04	1.69	1.62	2.27	1.76	2.33	2.05
Noncontrolling Interest Sharing Ratio	0.00%	-1.58%	-1.94%	-3.65%	-218.20%	-463.43%	497.53%	85.23%	32.06%	3.06%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.38	1.26	1.37	1.06	1.35	1.65	0.43	1.28	1.27
Quick Ratio	0.00	0.69	0.62	0.72	0.52	0.78	0.48	0.41	0.48	0.43
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-1,521	-463	-98	30	215	-846	4,954	-2,909	65
Operating Cash Flow to CapEx	0.00%	24.79%	57.97%	23.83%	164.94%	188.70%	160.81%	126.30%	118.03%	72.88%
Free Cash Flow to Firm to Interest Expense	0.00	-7.69	-1.48	-0.47	0.15	0.00	0.00	48.10	-26.21	0.58
Operating Cash Flow to Interest Expense	0.00	0.47	0.62	0.36	2.58	0.00	0.00	3.54	3.89	2.71
Operating Cash Flow Less CapEx to Interest Expense	0.00	-1.42	-0.45	-1.16	1.02	0.00	0.00	0.74	0.59	-1.01
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	1.25	1.49	1.46	1.45	1.22	1.36	1.62	1.53	1.52
Accounts Receivable Turnover	0.00	13.36	14.35	11.08	11.01	11.61	10.97	12.64	14.13	14.42
Inventory Turnover	0.00	7.12	8.07	7.71	7.90	7.34	4.28	0.00	0.00	5.38
Fixed Asset Turnover	0.00	3.21	3.73	3.49	3.15	2.57	3.07	0.00	0.00	3.04
Accounts Payable Turnover	0.00	5.02	5.62	5.22	5.27	4.82	4.66	4.81	4.51	4.70
Days Sales Outstanding (DSO)	0.00	27.32	25.44	32.96	33.14	31.45	33.26	28.87	25.83	25.30
Days Inventory Outstanding (DIO)	0.00	51.26	45.24	47.32	46.20	49.75	85.34	0.00	0.00	67.84
Days Payable Outstanding (DPO)	0.00	72.77	64.89	69.88	69.28	75.72	78.27	75.96	80.94	77.60
Cash Conversion Cycle (CCC)	0.00	5.81	5.78	10.40	10.07	5.47	40.32	-47.09	-55.11	15.55
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	1,505	1,765	2,108	2,322	2,214	3,512	-722	2,448	2,504
Invested Capital Turnover	0.00	6.63	3.85	3.36	2.99	2.63	2.43	6.12	9.07	2.96
Increase / (Decrease) in Invested Capital	0.00	1,505	259	344	214	-108	1,298	-4,234	3,170	56
Enterprise Value (EV)	0.00	0.00	0.00	3,222	4,748	4,844	5,245	4,229	4,610	3,306
Market Capitalization	0.00	0.00	0.00	940	1,822	1,929	2,507	1,676	2,880	1,508
Book Value per Share	$0.00	$0.00	($2.92)	($1.04)	($4.26)	($4.74)	($1.18)	$2.35	$4.98	$4.81
Tangible Book Value per Share	$0.00	$0.00	($7.13)	($5.22)	($8.59)	($8.98)	($5.30)	($1.67)	$3.97	$3.83
Total Capital	0.00	1,997	2,172	2,331	2,554	2,797	2,739	3,063	2,671	2,645
Total Debt	0.00	2,596	2,555	2,462	2,650	2,921	2,410	2,258	1,929	1,918
Total Long-Term Debt	0.00	2,484	2,428	2,462	2,424	2,808	2,118	2,056	1,888	1,879
Net Debt	0.00	2,214	2,231	2,273	2,442	2,385	2,243	2,081	1,706	1,777
Capital Expenditures (CapEx)	0.00	373	332	317	304	216	251	289	366	413
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	156	153	261	107	40	1,384	-1,010	254	286
Debt-free Net Working Capital (DFNWC)	0.00	521	476	449	313	577	1,551	-832	477	427
Net Working Capital (NWC)	0.00	408	348	449	88	464	1,259	-1,034	436	388
Net Nonoperating Expense (NNE)	276	-12	-166	28	172	128	156	405	104	61
Net Nonoperating Obligations (NNO)	0.00	2,105	2,148	2,239	2,417	2,337	3,183	-1,527	1,706	1,777
Total Depreciation and Amortization (D&A)	0.00	163	205	225	287	316	302	290	300	304
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	3.12%	2.43%	4.01%	1.61%	0.68%	19.88%	-11.84%	3.25%	3.90%
Debt-free Net Working Capital to Revenue	0.00%	10.44%	7.56%	6.89%	4.72%	9.67%	22.27%	-9.76%	6.10%	5.82%
Net Working Capital to Revenue	0.00%	8.18%	5.54%	6.89%	1.32%	7.78%	18.08%	-12.12%	5.57%	5.29%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($0.28)	$1.40	$0.43	($0.15)	$1.82	$2.10	$0.85	$0.38
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	134.51M	136.00M	137.87M	138.74M	141.00M	143.63M	146.13M	143.52M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($0.28)	$1.37	$0.41	($0.15)	$1.75	$2.06	$0.84	$0.38
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	134.51M	136.00M	137.87M	138.74M	147.17M	146.61M	149.24M	143.52M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	134.51M	136.00M	137.87M	139.96M	141.68M	144.30M	146.82M	143.52M
Normalized Net Operating Profit after Tax (NOPAT)	30	185	229	246	244	107	453	240	261	190
Normalized NOPAT Margin	0.55%	3.70%	3.64%	3.78%	3.67%	1.79%	6.50%	2.81%	3.34%	2.60%
Pre Tax Income Margin	-11.68%	1.37%	0.94%	3.90%	1.39%	-0.70%	5.15%	1.76%	2.96%	1.84%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	1.42	1.30	2.22	1.47	0.00	0.00	2.46	3.09	2.22
NOPAT to Interest Expense	0.00	-0.08	-0.65	1.18	1.25	0.00	0.00	6.99	2.35	1.09
EBIT Less CapEx to Interest Expense	0.00	-0.47	0.24	0.70	-0.09	0.00	0.00	-0.35	-0.21	-1.50
NOPAT Less CapEx to Interest Expense	0.00	-1.97	-1.71	-0.34	-0.31	0.00	0.00	4.19	-0.94	-2.63
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	-50.00%	0.00%	0.00%	6.25%	0.00%	0.76%	0.63%	1.91%	8.33%
Augmented Payout Ratio	0.00%	-50.00%	0.00%	0.00%	6.25%	0.00%	0.76%	0.63%	1.91%	140.00%

This table displays calculated financial ratios and metrics derived from Constellium's official financial filings.

Metric	Q1 2025
Period end date	3/31/2025
Growth Metrics	-
Revenue Growth	5.27%
EBITDA Growth	26.52%
EBIT Growth	56.14%
NOPAT Growth	4.75%
Net Income Growth	72.73%
EPS Growth	85.71%
Operating Cash Flow Growth	56.76%
Free Cash Flow Firm Growth	0.00%
Invested Capital Growth	0.00%
Revenue Q/Q Growth	0.00%
EBITDA Q/Q Growth	0.00%
EBIT Q/Q Growth	0.00%
NOPAT Q/Q Growth	0.00%
Net Income Q/Q Growth	0.00%
EPS Q/Q Growth	0.00%
Operating Cash Flow Q/Q Growth	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%
Invested Capital Q/Q Growth	0.00%
Profitability Metrics	-
Gross Margin	13.29%
EBITDA Margin	8.44%
Operating Margin	4.75%
EBIT Margin	4.50%
Profit (Net Income) Margin	1.92%
Tax Burden Percent	61.29%
Interest Burden Percent	69.66%
Effective Tax Rate	38.71%
Return on Invested Capital (ROIC)	16.71%
ROIC Less NNEP Spread (ROIC-NNEP)	14.56%
Return on Net Nonoperating Assets (RNNOA)	34.74%
Return on Equity (ROE)	51.45%
Cash Return on Invested Capital (CROIC)	0.00%
Operating Return on Assets (OROA)	6.47%
Return on Assets (ROA)	2.76%
Return on Common Equity (ROCE)	50.11%
Return on Equity Simple (ROE_SIMPLE)	10.20%
Net Operating Profit after Tax (NOPAT)	58
NOPAT Margin	2.91%
Net Nonoperating Expense Percent (NNEP)	2.15%
Return On Investment Capital (ROIC_SIMPLE)	2.13%
Cost of Revenue to Revenue	86.71%
SG&A Expenses to Revenue	3.94%
R&D to Revenue	0.66%
Operating Expenses to Revenue	8.54%
Earnings before Interest and Taxes (EBIT)	89
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	167
Valuation Ratios	-
Price to Book Value (P/BV)	1.94
Price to Tangible Book Value (P/TBV)	2.39
Price to Revenue (P/Rev)	0.19
Price to Earnings (P/E)	20.11
Dividend Yield	0.00%
Earnings Yield	4.97%
Enterprise Value to Invested Capital (EV/IC)	1.27
Enterprise Value to Revenue (EV/Rev)	0.44
Enterprise Value to EBITDA (EV/EBITDA)	5.63
Enterprise Value to EBIT (EV/EBIT)	11.85
Enterprise Value to NOPAT (EV/NOPAT)	24.87
Enterprise Value to Operating Cash Flow (EV/OCF)	10.23
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00
Leverage & Solvency	-
Debt to Equity	2.54
Long-Term Debt to Equity	2.49
Financial Leverage	2.39
Leverage Ratio	6.76
Compound Leverage Factor	4.71
Debt to Total Capital	71.75%
Short-Term Debt to Total Capital	1.29%
Long-Term Debt to Total Capital	70.46%
Preferred Equity to Total Capital	0.00%
Noncontrolling Interests to Total Capital	0.74%
Common Equity to Total Capital	27.51%
Debt to EBITDA	3.32
Net Debt to EBITDA	3.12
Long-Term Debt to EBITDA	3.26
Debt to NOPAT	14.67
Net Debt to NOPAT	13.78
Long-Term Debt to NOPAT	14.41
Altman Z-Score	1.79
Noncontrolling Interest Sharing Ratio	2.61%
Liquidity Ratios	-
Current Ratio	1.24
Quick Ratio	0.52
Cash Flow Metrics	-
Free Cash Flow to Firm (FCFF)	-2,532
Operating Cash Flow to CapEx	84.06%
Free Cash Flow to Firm to Interest Expense	-93.79
Operating Cash Flow to Interest Expense	2.15
Operating Cash Flow Less CapEx to Interest Expense	-0.41
Efficiency Ratios	-
Asset Turnover	1.44
Accounts Receivable Turnover	9.09
Inventory Turnover	5.07
Fixed Asset Turnover	3.03
Accounts Payable Turnover	3.89
Days Sales Outstanding (DSO)	40.16
Days Inventory Outstanding (DIO)	72.01
Days Payable Outstanding (DPO)	93.81
Cash Conversion Cycle (CCC)	18.36
Capital & Investment Metrics	-
Invested Capital	2,590
Invested Capital Turnover	5.74
Increase / (Decrease) in Invested Capital	2,590
Enterprise Value (EV)	3,293
Market Capitalization	1,448
Book Value per Share	$5.19
Tangible Book Value per Share	$4.22
Total Capital	2,708
Total Debt	1,943
Total Long-Term Debt	1,908
Net Debt	1,825
Capital Expenditures (CapEx)	69
Debt-free, Cash-free Net Working Capital (DFCFNWC)	345
Debt-free Net Working Capital (DFNWC)	463
Net Working Capital (NWC)	428
Net Nonoperating Expense (NNE)	20
Net Nonoperating Obligations (NNO)	1,825
Total Depreciation and Amortization (D&A)	78
Debt-free, Cash-free Net Working Capital to Revenue	4.64%
Debt-free Net Working Capital to Revenue	6.23%
Net Working Capital to Revenue	5.76%
Earnings Adjustments	-
Adjusted Basic Earnings per Share	$0.26
Adjusted Weighted Average Basic Shares Outstanding	142.92M
Adjusted Diluted Earnings per Share	$0.26
Adjusted Weighted Average Diluted Shares Outstanding	142.92M
Adjusted Basic & Diluted Earnings per Share	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	142.92M
Normalized Net Operating Profit after Tax (NOPAT)	58
Normalized NOPAT Margin	2.91%
Pre Tax Income Margin	3.13%
Debt Service Ratios	-
EBIT to Interest Expense	3.30
NOPAT to Interest Expense	2.13
EBIT Less CapEx to Interest Expense	0.74
NOPAT Less CapEx to Interest Expense	-0.42
Payout Ratios	-
Dividend Payout Ratio	7.89%
Augmented Payout Ratio	122.37%

Frequently Asked Questions About Constellium's Financials

When does Constellium's financial year end?

According to the most recent income statement we have on file, Constellium's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Constellium's net income changed over the last 9 years?

Constellium's net income appears to be on an upward trend, with a most recent value of $60 million in 2024, falling from -$599.77 million in 2015. The previous period was $157 million in 2023. Check out Constellium's forecast to explore projected trends and price targets.

What is Constellium's operating income?

Constellium's total operating income in 2024 was $272 million, based on the following breakdown:

Total Gross Profit: $938 million
Total Operating Expenses: $666 million

How has Constellium revenue changed over the last 9 years?

Over the last 9 years, Constellium's total revenue changed from $5.43 billion in 2015 to $7.34 billion in 2024, a change of 35.1%.

How much debt does Constellium have?

Constellium's total liabilities were at $4.01 billion at the end of 2024, a 4.4% decrease from 2023, and a 12.6% decrease since 2016.

How much cash does Constellium have?

In the past 8 years, Constellium's cash and equivalents has ranged from $141 million in 2024 to $536.28 million in 2020, and is currently $141 million as of their latest financial filing in 2024.

How has Constellium's book value per share changed over the last 9 years?

Over the last 9 years, Constellium's book value per share changed from 0.00 in 2015 to 4.81 in 2024, a change of 480.9%.

Related Companies

This page (NYSE:CSTM) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Constellium (CSTM) Financials

Frequently Asked Questions About Constellium's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Constellium (CSTM) Financials

Annual Income Statements for Constellium

Quarterly Income Statements for Constellium

Annual Cash Flow Statements for Constellium

Quarterly Cash Flow Statements for Constellium

Annual Balance Sheets for Constellium

Quarterly Balance Sheets for Constellium

Annual Metrics and Ratios for Constellium

Quarterly Metrics and Ratios for Constellium

Frequently Asked Questions About Constellium's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools